SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-003626
Filing Date
2024-03-20
Accepted
2024-03-20 16:05:45
Documents
116
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 20-F lvtx-20231231x20f.htm   iXBRL 20-F 3724293
2 EX-2.1 lvtx-20231231xex2d1.htm EX-2.1 197706
3 EX-12.1 lvtx-20231231xex12d1.htm EX-12.1 25334
4 EX-12.2 lvtx-20231231xex12d2.htm EX-12.2 24873
5 EX-13.1 lvtx-20231231xex13d1.htm EX-13.1 10712
6 EX-13.2 lvtx-20231231xex13d2.htm EX-13.2 10838
7 EX-15.1 lvtx-20231231xex15d1.htm EX-15.1 3034
8 EX-97.1 lvtx-20231231xex97d1.htm EX-97.1 46106
9 GRAPHIC lvtx-20231231x20f001.jpg GRAPHIC 7670
10 GRAPHIC lvtx-20231231x20f002.jpg GRAPHIC 91291
11 GRAPHIC lvtx-20231231x20f003.jpg GRAPHIC 12125
12 GRAPHIC lvtx-20231231x20f004.jpg GRAPHIC 71238
13 GRAPHIC lvtx-20231231xex97d1001.jpg GRAPHIC 8288
  Complete submission text file 0001558370-24-003626.txt   12998218

Data Files

Seq Description Document Type Size
14 EX-101.SCH lvtx-20231231.xsd EX-101.SCH 93428
15 EX-101.CAL lvtx-20231231_cal.xml EX-101.CAL 64093
16 EX-101.DEF lvtx-20231231_def.xml EX-101.DEF 260153
17 EX-101.LAB lvtx-20231231_lab.xml EX-101.LAB 608136
18 EX-101.PRE lvtx-20231231_pre.xml EX-101.PRE 475035
120 EXTRACTED XBRL INSTANCE DOCUMENT lvtx-20231231x20f_htm.xml XML 2345658
Mailing Address YALELAAN 62 UTRECHT P7 3584 CM
Business Address YALELAAN 62 UTRECHT P7 3584 CM 31 6 3000 3035
LAVA Therapeutics NV (Filer) CIK: 0001840748 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-40241 | Film No.: 24767802
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)